• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统计算发现蛋白质组中的新型溶质载体样蛋白。

Systematic in silico discovery of novel solute carrier-like proteins from proteomes.

机构信息

Membrane Transport Discovery Lab, Department of Nephrology and Hypertension and Department for BioMedical Research, Inselspital, University of Bern, Bern, Switzerland.

出版信息

PLoS One. 2022 Jul 28;17(7):e0271062. doi: 10.1371/journal.pone.0271062. eCollection 2022.

DOI:10.1371/journal.pone.0271062
PMID:35901096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9333335/
Abstract

Solute carrier (SLC) proteins represent the largest superfamily of transmembrane transporters. While many of them play key biological roles, their systematic analysis has been hampered by their functional and structural heterogeneity. Based on available nomenclature systems, we hypothesized that many as yet unidentified SLC transporters exist in the human genome, which await further systematic analysis. Here, we present criteria for defining "SLC-likeness" to curate a set of "SLC-like" protein families from the Transporter Classification Database (TCDB) and Protein families (Pfam) databases. Computational sequence similarity searches surprisingly identified ~120 more proteins in human with potential SLC-like properties compared to previous annotations. Interestingly, several of these have documented transport activity in the scientific literature. To complete the overview of the "SLC-ome", we present an algorithm to classify SLC-like proteins into protein families, investigating their known functions and evolutionary relationships to similar proteins from 6 other clinically relevant experimental organisms, and pinpoint structural orphans. We envision that our work will serve as a stepping stone for future studies of the biological function and the identification of the natural substrates of the many under-explored SLC transporters, as well as for the development of new therapeutic applications, including strategies for personalized medicine and drug delivery.

摘要

溶质载体 (SLC) 蛋白代表了最大的跨膜转运蛋白超家族。虽然它们中的许多都发挥着关键的生物学作用,但由于其功能和结构的异质性,对它们的系统分析一直受到阻碍。基于现有的命名系统,我们假设在人类基因组中存在许多尚未被识别的 SLC 转运蛋白,这些蛋白有待进一步的系统分析。在这里,我们提出了定义“SLC 相似性”的标准,从 Transporter Classification Database (TCDB) 和 Protein families (Pfam) 数据库中整理出一组“SLC 样”蛋白家族。令人惊讶的是,与之前的注释相比,通过计算序列相似性搜索在人类中鉴定出了大约 120 个具有潜在 SLC 样特性的蛋白质。有趣的是,其中有几个在科学文献中已有转运活性的记录。为了全面了解“SLC 组”,我们提出了一种将 SLC 样蛋白分类为蛋白家族的算法,研究了它们的已知功能以及与来自其他 6 种临床相关实验生物的类似蛋白的进化关系,并确定了结构孤儿。我们设想,我们的工作将为未来研究这些未充分探索的 SLC 转运蛋白的生物学功能和鉴定天然底物以及开发新的治疗应用铺平道路,包括个性化医疗和药物输送的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ea/9333335/e25570153a71/pone.0271062.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ea/9333335/e9bb08ba96f8/pone.0271062.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ea/9333335/e354f992f2e8/pone.0271062.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ea/9333335/b7f2fa716c26/pone.0271062.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ea/9333335/16bb57da9447/pone.0271062.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ea/9333335/e25570153a71/pone.0271062.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ea/9333335/e9bb08ba96f8/pone.0271062.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ea/9333335/e354f992f2e8/pone.0271062.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ea/9333335/b7f2fa716c26/pone.0271062.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ea/9333335/16bb57da9447/pone.0271062.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ea/9333335/e25570153a71/pone.0271062.g005.jpg

相似文献

1
Systematic in silico discovery of novel solute carrier-like proteins from proteomes.系统计算发现蛋白质组中的新型溶质载体样蛋白。
PLoS One. 2022 Jul 28;17(7):e0271062. doi: 10.1371/journal.pone.0271062. eCollection 2022.
2
The genetic landscape of the human solute carrier (SLC) transporter superfamily.人类溶质载体(SLC)转运蛋白超家族的遗传景观。
Hum Genet. 2019 Dec;138(11-12):1359-1377. doi: 10.1007/s00439-019-02081-x. Epub 2019 Nov 2.
3
Rational exploration of fold atlas for human solute carrier proteins.理性探索人溶质载体蛋白的折叠图谱。
Structure. 2022 Sep 1;30(9):1321-1330.e5. doi: 10.1016/j.str.2022.05.015. Epub 2022 Jun 13.
4
A guide to plasma membrane solute carrier proteins.质膜溶质载体蛋白指南。
FEBS J. 2021 May;288(9):2784-2835. doi: 10.1111/febs.15531. Epub 2020 Sep 18.
5
Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.建立一种新型的微量热泳动配体结合测定法,以寡肽转运体PepT1(SLC15家族)为模型系统来表征SLC溶质载体。
J Pharmacol Toxicol Methods. 2018 Jul-Aug;92:67-76. doi: 10.1016/j.vascn.2018.03.004. Epub 2018 Mar 23.
6
The Identification and Evolutionary Trends of the Solute Carrier Superfamily in Arthropods.节肢动物中溶质载体超家族的鉴定及进化趋势
Genome Biol Evol. 2020 Aug 1;12(8):1429-1439. doi: 10.1093/gbe/evaa153.
7
A phylogenetic analysis between humans and D. melanogaster: A repertoire of solute carriers in humans and flies.人类与黑腹果蝇之间的系统发生分析:人类和果蝇中的溶质载体谱。
Gene. 2022 Jan 30;809:146033. doi: 10.1016/j.gene.2021.146033. Epub 2021 Oct 18.
8
Potentiating SLC transporter activity: Emerging drug discovery opportunities.增强 SLC 转运体活性:新兴的药物发现机会。
Biochem Pharmacol. 2017 Jul 1;135:1-11. doi: 10.1016/j.bcp.2017.02.010. Epub 2017 Feb 16.
9
The solute carrier families have a remarkably long evolutionary history with the majority of the human families present before divergence of Bilaterian species.溶质载体家族拥有非常悠久的进化历史,其中大多数人类家族在两侧对称物种分化之前就已经存在。
Mol Biol Evol. 2011 Apr;28(4):1531-41. doi: 10.1093/molbev/msq350. Epub 2010 Dec 24.
10
Expression analysis of human solute carrier (SLC) family transporters in nasal mucosa and RPMI 2650 cells.人溶质载体(SLC)家族转运蛋白在鼻黏膜和 RPMI 2650 细胞中的表达分析。
Eur J Pharm Sci. 2018 Oct 15;123:277-294. doi: 10.1016/j.ejps.2018.07.040. Epub 2018 Jul 21.

引用本文的文献

1
A data-mining analysis of host solute carrier family proteins in SARS-CoV-2 infection with reference to brain endothelial cells and the blood-brain barrier in COVID-19.参照新冠病毒感染中脑内皮细胞和血脑屏障对严重急性呼吸综合征冠状病毒2感染中宿主溶质载体家族蛋白的数据挖掘分析。
Front Neurol. 2025 Jul 1;16:1563040. doi: 10.3389/fneur.2025.1563040. eCollection 2025.
2
Update of the sideroflexin (SLC56) gene family.铁转运黄素蛋白(SLC56)基因家族的更新
Hum Genomics. 2025 Jun 20;19(1):69. doi: 10.1186/s40246-025-00779-w.
3
The solute carrier superfamily interactome.

本文引用的文献

1
The modified mitochondrial outer membrane carrier MTCH2 links mitochondrial fusion to lipogenesis.线粒体膜外载体 MTCH2 可将线粒体融合与脂肪生成联系起来。
J Cell Biol. 2021 Nov 1;220(11). doi: 10.1083/jcb.202103122. Epub 2021 Sep 29.
2
The lysosomal protein ABCD4 can transport vitamin B across liposomal membranes in vitro.溶酶体蛋白 ABCD4 可在体外将维生素 B 跨脂质体膜转运。
J Biol Chem. 2021 Jan-Jun;296:100654. doi: 10.1016/j.jbc.2021.100654. Epub 2021 May 3.
3
Structural basis for the Mg recognition and regulation of the CorC Mg transporter.
溶质载体超家族相互作用组
Mol Syst Biol. 2025 May 12. doi: 10.1038/s44320-025-00109-1.
4
Metabolic mapping of the human solute carrier superfamily.人类溶质载体超家族的代谢图谱
Mol Syst Biol. 2025 May 12. doi: 10.1038/s44320-025-00106-4.
5
Integrative Approaches to Soybean Resilience, Productivity, and Utility: A Review of Genomics, Computational Modeling, and Economic Viability.大豆抗逆性、生产力和实用性的综合研究方法:基因组学、计算建模与经济可行性综述
Plants (Basel). 2025 Feb 21;14(5):671. doi: 10.3390/plants14050671.
6
A hybrid machine learning framework for functional annotation of mitochondrial glutathione transport and metabolism proteins in cancers.一种用于癌症中线粒体谷胱甘肽转运和代谢蛋白功能注释的混合机器学习框架。
BMC Bioinformatics. 2025 Feb 11;26(1):48. doi: 10.1186/s12859-025-06051-1.
7
Predicting substrates for orphan solute carrier proteins using multi-omics datasets.使用多组学数据集预测孤儿溶质载体蛋白的底物
BMC Genomics. 2025 Feb 11;26(1):130. doi: 10.1186/s12864-025-11330-5.
8
The impact of solute carrier proteins on disrupting substance regulation in metabolic disorders: insights and clinical applications.溶质载体蛋白对破坏代谢紊乱中物质调节的影响:见解与临床应用。
Front Pharmacol. 2025 Jan 9;15:1510080. doi: 10.3389/fphar.2024.1510080. eCollection 2024.
9
Cryo-EM reveals cholesterol binding in the lysosomal GPCR-like protein LYCHOS.冷冻电镜揭示了溶酶体类GPCR蛋白LYCHOS中胆固醇的结合情况。
Nat Struct Mol Biol. 2025 May;32(5):896-904. doi: 10.1038/s41594-024-01470-9. Epub 2025 Jan 17.
10
Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits.代谢组学与外显子组测序相结合揭示了罕见有害杂合变异对基因功能和人类性状的分级影响。
Nat Genet. 2025 Jan;57(1):193-205. doi: 10.1038/s41588-024-01965-7. Epub 2025 Jan 2.
CorC 镁转运蛋白对镁的识别与调控的结构基础
Sci Adv. 2021 Feb 10;7(7). doi: 10.1126/sciadv.abe6140. Print 2021 Feb.
4
In silico prediction of structure and function for a large family of transmembrane proteins that includes human Tmem41b.计算机预测包括人类 Tmem41b 在内的一大类跨膜蛋白的结构和功能。
F1000Res. 2020 Dec 3;9:1395. doi: 10.12688/f1000research.27676.2. eCollection 2020.
5
Complexity of the eukaryotic dolichol-linked oligosaccharide scramblase suggested by activity correlation profiling mass spectrometry.活性相关谱分析质谱法揭示真核生物多萜醇连接寡糖移位酶的复杂性。
Sci Rep. 2021 Jan 14;11(1):1411. doi: 10.1038/s41598-020-80956-0.
6
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.基于全基因组鉴定 SARS-CoV-2 和泛冠状病毒宿主因子网络。
Cell. 2021 Jan 7;184(1):120-132.e14. doi: 10.1016/j.cell.2020.12.006. Epub 2020 Dec 9.
7
TMEM41B Is a Pan-flavivirus Host Factor.TMEM41B 是泛黄病毒宿主因子。
Cell. 2021 Jan 7;184(1):133-148.e20. doi: 10.1016/j.cell.2020.12.005. Epub 2020 Dec 9.
8
A novel three-TMH Na/H antiporter and the functional role of its oligomerization.一种新型三 TMH Na/H 反向转运蛋白及其寡聚化的功能作用。
J Mol Biol. 2021 Jan 22;433(2):166730. doi: 10.1016/j.jmb.2020.166730. Epub 2020 Dec 3.
9
Sequence Features of Mitochondrial Transporter Protein Families.线粒体转运蛋白家族的序列特征。
Biomolecules. 2020 Nov 28;10(12):1611. doi: 10.3390/biom10121611.
10
The Transporter Classification Database (TCDB): 2021 update.《转运蛋白分类数据库(TCDB):2021 年更新》。
Nucleic Acids Res. 2021 Jan 8;49(D1):D461-D467. doi: 10.1093/nar/gkaa1004.